Corticotropin-Releasing Factor Testing Reveals a Dose-Dependent Difference in Methadone Maintained Vs Control Subjects
- 8 January 2003
- journal article
- research article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 28 (5) , 985-994
- https://doi.org/10.1038/sj.npp.1300156
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuseAmerican Journal of Medical Genetics, 2002
- A Genome‐Wide Search for Genes That Relate to a Low Level of Response to AlcoholAlcohol, Clinical and Experimental Research, 2001
- μ opioid receptor gene variants: lack of association with alcohol dependenceMolecular Psychiatry, 1997
- Human mu opioid receptor gene polymorphisms and vulnerability to substance abuseAddiction Biology, 1997
- A preliminary study of beta endorphin during chronic naltrexone maintenance treatment in ex-opiate addictsLife Sciences, 1986
- Differences in Hypothalamo-Pituitary-Adrenocortical Activity in the Rat after Acute and Prolonged Treatment with MorphineNeuroendocrinology, 1984
- Circadian rhythms and levels of β-endorphin, acth, and cortisol during chronic methadone maintenance treatment in humansLife Sciences, 1983
- Short-term hormonal effects of naloxone in manPsychoneuroendocrinology, 1980
- Stereoselective disposition of methadone in manLife Sciences, 1979
- Catecholamine and 17-hydroxycorticosteroid excretion during a cycle of morphine dependence in manJournal of Psychiatric Research, 1969